$467.24+6.48 (+1.41%)
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
HCA Healthcare, Inc. in the Healthcare sector is trading at $463.93 with a market capitalization of $99.3B. Wall Street consensus targets $460.59 (22 analysts), implying a -0.7% move over the next 12 months. The stock is currently 17% below its 52-week high of $556.52, remaining 4.6% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $20.23B↑ | $19.11B↓ | $19.51B↑ | $19.16B↑ | $18.61B |
| Gross Profit | $9.05B↑ | $7.97B↓ | $8.18B↑ | $8.02B↑ | $7.62B |
| Operating Income | $3.07B↑ | $2.86B↓ | $3.18B↑ | $2.96B | $2.97B |
| Net Income | $1.70B↑ | $1.62B↓ | $1.88B↑ | $1.64B↓ | $1.65B |
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic a...
Academic risk and quality models computed from HCA's own filings and price history, not from analyst opinion.
Strong on 7 of 9 fundamental-health tests covering profitability, leverage and operating efficiency.
Altman Z in the 1.81 to 2.99 grey zone, the band where the model gives no clear bankruptcy verdict.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, above the current 28.7% reading.
Fama-French 5-factor market beta. The five factors explain 16% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.